Delivery Order SPE2DB22D2206-SPE2DB25FKD86
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,805.40 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,363.39 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100s) on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price contract, classified as a non-set-aside competitive award, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of OxyContin ER 40 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $5,399.46, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award was competitively procured with no set-aside...
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency awarded a $1,505.16 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for OxyContin ER 40 mg tablets (100-count units). This is a firm fixed-price contract with an ultimate completion date of September 8, 2025, and represents a non-competitive delivery order executed under the company's existing indefinite delivery contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,577.23 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 40 mg tablets (100 count) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price, non-set-aside delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance...
- The Defense Logistics Agency awarded a $1,321.72 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of OxyContin ER 30 mg tablets (100-count packages). This is a firm fixed price, non-set-aside contract with a completion date of August 27, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of OxyContin ER 10 mg tablets (100-count) valued at $3,143.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD86Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for OxyContin ER 40 mg tablets (100-count units) with a ceiling value of $1,754.92. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains, including brand-name and generic medications, vaccines, and specialized medical commodities. All of the company's reviewed contract awards with DLA have been competitively awarded with firm fixed pricing, demonstrating its capability to meet federal procurement requirements through open competition. This delivery order for pain management pharmaceuticals supports DLA's mission to supply medical commodities to defense health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/29/25 |